ClinicalTrials.Veeva

Menu

French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator (DAI-T4F)

P

Paris Sudden Death Expertise Center

Status

Enrolling

Conditions

Tetralogy of Fallot
Implantable Defibrillator User
Ventricular Arrythmia
Congenital Heart Disease
Sudden Cardiac Death

Study type

Observational

Funder types

Other

Identifiers

NCT03837574
CNIL2029070

Details and patient eligibility

About

National french registry of patients with tetralogy of Fallot and implantable cardioverter defibrillator.

Full description

Inclusion criteria:

  • patient with tetralogy of Fallot > 18 years
  • implantable cardioverter defibrillator (ICD)
  • primary or secondary prevention

All french centers performing ICD implantation are annually contacted to include all patients with tetralogy of Fallot and ICD.

Retrospective inclusion of cases before 2010 and prospective inclusion after 2010 with prospective follow up and annual update.

All events are centrally adjudicated with collection of all baseline ECG and reviewing of endocavitary EGM.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • tetralogy of Fallot
  • implantable cardioverter defibrillator

Exclusion criteria

  • age < 18 years

Trial contacts and locations

1

Loading...

Central trial contact

Victor Waldmann, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems